Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th

Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026

Modular Medical Secures National PBM Contract For Pivot Insulin Pump

Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump

Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements

EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades

Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday, September 4, 2026

Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference

Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026

Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman

Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records

Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump

Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery

Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements

Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump

Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps

Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion

Modular Medical Launches New Website for Pivot Tubeless Insulin Patch Pump

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump

Modular Medical Announces 1-for-30 Reverse Stock Split

Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market

Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump

Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule

Modular Medical Announces Pricing of $4.68 Million Public Offering

Modular Medical Announces Proposed Public Offering

Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump

Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance

Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System

Modular Medical Announces Ongoing Progress to Obtain CE Mark

Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System

Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion

Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration

Modular Medical Announces First Human Use of MODD1 Pump Delivering Insulin

Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production

Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions

Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025

Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

Modular Medical Announces $12 Million Private Placement

Modular Medical Announces BSI Group as Trusted Body for CE Mark Clearance